Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What excipients are combined with ruxolitinib in apotex's medication?Patent expiration date of guselkumab?Drug patent watch trametinib?Pramlintide acetate price?What are alcohol's effects on ozempic?
See the DrugPatentWatch profile for artesunate
During treatment with artesunate, which is an antimalarial medication used to treat severe malaria caused by Plasmodium falciparum, adjusting the dosage may be necessary in patients who experience hypersensitivity reactions or allergies [1]. However, specific guidance on dosage adjustments in response to allergies is limited, and healthcare providers should exercise caution when making these decisions. In general, artesunate is administered intravenously in a hospital setting for treatment of severe malaria. The standard dose of artesunate for adult patients is typically 2.4 mg/kg intravenously every 12 hours, but the dosage can vary depending on the severity of the illness and the patient's response to treatment [2]. For patients who develop a severe allergic reaction or hypersensitivity to artesunate, the medication may need to be discontinued, and alternative antimalarial therapies should be considered. While there is no specific guidance from regulatory authorities on dosage adjustments in response to allergies, it is generally recommended that patients who experience a severe allergic reaction or hypersensitivity to artesunate should not be re-exposed to the medication [3]. Patients who have a history of hypersensitivity reactions to antimalarial medications, including artesunate, should also be evaluated for alternative treatments [4]. It is essential to note that healthcare providers should closely monitor patients receiving artesunate for signs of hypersensitivity reactions, such as rash, itching, difficulty breathing, or rapid heart rate. If a patient experiences any of these symptoms, the medication should be discontinued immediately and alternative treatments should be initiated. Sources: [1] https://www.drugs.com/monograph/artesunate.html [2] DrugPatentWatch.com: Artesunate Dosage [link https://www.drugpatentwatch.com/drugs/artesunate] [3] https://www.cdc.gov/malaria/about/treatment/artesunate.html [4] https://www.ncbi.nlm.nih.gov/books/NBK547739/ Note: The dosage recommendations for artesunate may vary depending on the specific condition being treated, the patient's medical history, and other factors. It is essential to consult the latest guidelines and recommendations from regulatory authorities and healthcare professionals before making any treatment decisions.
Other Questions About Artesunate :